Abbott Laboratories stock at USD 100.95 on September 28, 2026

Abbott Laboratories last traded at USD 100.95 on September 28, 2026, down 0.34 percent from the prior close. The company also announced a Lingo partnership and agreed to a USD 384,999,040 settlement.

Trading session

Abbott Laboratories shares last traded at USD 100.95 on the NYSE at 17:58:24 UTC on September 28, 2026. The stock was down USD 0.34, or 0.34 percent, from the prior close of USD 101.29.

Recent company developments

Abbott and Berry Street announced an exclusive partnership on September 23 to combine Abbott's Lingo over-the-counter continuous glucose monitor with Berry Street's insurance-covered registered dietitian support. The companies said users can access dietitians trained on Lingo, receive nutrition recommendations informed by glucose trends and meet virtually for one-to-one appointments. Berry Street users are eligible for a 15 percent discount on four-week Lingo plans, according to Abbott's release.

The U.S. Department of Justice said on September 14 that Abbott Laboratories agreed to pay USD 384,999,040 to resolve allegations involving infant formula and nutritional therapy products manufactured between January 1, 2018, and December 31, 2022. The settlement includes USD 348,700,868 for the United States and USD 36,298,172 for certain states. The department said the resolved claims are allegations only and that there has been no determination of liability, according to the Justice Department.